Eintrag weiter verarbeiten
Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases
Gespeichert in:
| Zeitschriftentitel: | Anti-Cancer Drugs |
|---|---|
| Personen und Körperschaften: | , |
| In: | Anti-Cancer Drugs, 17, 2006, 2, S. 133-138 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Ovid Technologies (Wolters Kluwer Health)
|
| Schlagwörter: |
| author_facet |
Koukourakis, Michael I. Maltezos, Efstratios Koukourakis, Michael I. Maltezos, Efstratios |
|---|---|
| author |
Koukourakis, Michael I. Maltezos, Efstratios |
| spellingShingle |
Koukourakis, Michael I. Maltezos, Efstratios Anti-Cancer Drugs Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases Cancer Research Pharmacology (medical) Pharmacology Oncology |
| author_sort |
koukourakis, michael i. |
| spelling |
Koukourakis, Michael I. Maltezos, Efstratios 0959-4973 Ovid Technologies (Wolters Kluwer Health) Cancer Research Pharmacology (medical) Pharmacology Oncology http://dx.doi.org/10.1097/00001813-200602000-00003 Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases Anti-Cancer Drugs |
| doi_str_mv |
10.1097/00001813-200602000-00003 |
| facet_avail |
Online |
| finc_class_facet |
Chemie und Pharmazie Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5Ny8wMDAwMTgxMy0yMDA2MDIwMDAtMDAwMDM |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5Ny8wMDAwMTgxMy0yMDA2MDIwMDAtMDAwMDM |
| institution |
DE-Zi4 DE-Gla1 DE-15 DE-Pl11 DE-Rs1 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-D161 |
| imprint |
Ovid Technologies (Wolters Kluwer Health), 2006 |
| imprint_str_mv |
Ovid Technologies (Wolters Kluwer Health), 2006 |
| issn |
0959-4973 |
| issn_str_mv |
0959-4973 |
| language |
English |
| mega_collection |
Ovid Technologies (Wolters Kluwer Health) (CrossRef) |
| match_str |
koukourakis2006amifostineadministrationduringradiotherapyforcancerpatientswithgeneticautoimmunemetabolicandotherdiseases |
| publishDateSort |
2006 |
| publisher |
Ovid Technologies (Wolters Kluwer Health) |
| recordtype |
ai |
| record_format |
ai |
| series |
Anti-Cancer Drugs |
| source_id |
49 |
| title |
Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases |
| title_unstemmed |
Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases |
| title_full |
Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases |
| title_fullStr |
Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases |
| title_full_unstemmed |
Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases |
| title_short |
Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases |
| title_sort |
amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases |
| topic |
Cancer Research Pharmacology (medical) Pharmacology Oncology |
| url |
http://dx.doi.org/10.1097/00001813-200602000-00003 |
| publishDate |
2006 |
| physical |
133-138 |
| description |
|
| container_issue |
2 |
| container_start_page |
133 |
| container_title |
Anti-Cancer Drugs |
| container_volume |
17 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792333949041639424 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T14:20:52.743Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Amifostine+administration+during+radiotherapy+for+cancer+patients+with+genetic%2C+autoimmune%2C+metabolic+and+other+diseases&rft.date=2006-02-01&genre=article&issn=0959-4973&volume=17&issue=2&spage=133&epage=138&pages=133-138&jtitle=Anti-Cancer+Drugs&atitle=Amifostine+administration+during+radiotherapy+for+cancer+patients+with+genetic%2C+autoimmune%2C+metabolic+and+other+diseases&aulast=Maltezos&aufirst=Efstratios&rft_id=info%3Adoi%2F10.1097%2F00001813-200602000-00003&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792333949041639424 |
| author | Koukourakis, Michael I., Maltezos, Efstratios |
| author_facet | Koukourakis, Michael I., Maltezos, Efstratios, Koukourakis, Michael I., Maltezos, Efstratios |
| author_sort | koukourakis, michael i. |
| container_issue | 2 |
| container_start_page | 133 |
| container_title | Anti-Cancer Drugs |
| container_volume | 17 |
| description | |
| doi_str_mv | 10.1097/00001813-200602000-00003 |
| facet_avail | Online |
| finc_class_facet | Chemie und Pharmazie, Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5Ny8wMDAwMTgxMy0yMDA2MDIwMDAtMDAwMDM |
| imprint | Ovid Technologies (Wolters Kluwer Health), 2006 |
| imprint_str_mv | Ovid Technologies (Wolters Kluwer Health), 2006 |
| institution | DE-Zi4, DE-Gla1, DE-15, DE-Pl11, DE-Rs1, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161 |
| issn | 0959-4973 |
| issn_str_mv | 0959-4973 |
| language | English |
| last_indexed | 2024-03-01T14:20:52.743Z |
| match_str | koukourakis2006amifostineadministrationduringradiotherapyforcancerpatientswithgeneticautoimmunemetabolicandotherdiseases |
| mega_collection | Ovid Technologies (Wolters Kluwer Health) (CrossRef) |
| physical | 133-138 |
| publishDate | 2006 |
| publishDateSort | 2006 |
| publisher | Ovid Technologies (Wolters Kluwer Health) |
| record_format | ai |
| recordtype | ai |
| series | Anti-Cancer Drugs |
| source_id | 49 |
| spelling | Koukourakis, Michael I. Maltezos, Efstratios 0959-4973 Ovid Technologies (Wolters Kluwer Health) Cancer Research Pharmacology (medical) Pharmacology Oncology http://dx.doi.org/10.1097/00001813-200602000-00003 Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases Anti-Cancer Drugs |
| spellingShingle | Koukourakis, Michael I., Maltezos, Efstratios, Anti-Cancer Drugs, Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases, Cancer Research, Pharmacology (medical), Pharmacology, Oncology |
| title | Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases |
| title_full | Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases |
| title_fullStr | Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases |
| title_full_unstemmed | Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases |
| title_short | Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases |
| title_sort | amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases |
| title_unstemmed | Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases |
| topic | Cancer Research, Pharmacology (medical), Pharmacology, Oncology |
| url | http://dx.doi.org/10.1097/00001813-200602000-00003 |